InsiderTrades.com logo
Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
From Legacy Research   |   Ad
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More

AUP Insider Trading (Aurinia Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$2,246,339.92
Insider Selling (Last 12 Months): C$4,004,215.00

Aurinia Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Aurinia Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aurinia Pharmaceuticals Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 07/30/2021 01:00 AM ET

This chart shows the closing price history over time for AUP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Man who called 2020 Crash warns of huge event in 2022
From Stansberry   |   Ad
A historic event in 2022 will cause a massive shift in the wealth divide. It could leave thousands of Americans under age 50 better off… while retirees will be left holding the scraps.
Details here…

Aurinia Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2021Michael Robert MartinDirectorBuy29,000C$28.82C$835,780.0061,824
11/10/2021Neil SolomonsSenior OfficerBuy70,000C$8.00C$559,944.00157,299
11/9/2021Michael Robert MartinDirectorSell50,000C$39.82C$1,991,220.0092,824
10/25/2021Robert HuizingaSenior OfficerBuy95,000C$4.22C$401,280.00195,728
9/21/2021Robert HuizingaSenior OfficerBuy16,000C$3.47C$55,545.60122,092
9/20/2021Michael Robert MartinDirectorBuy28,500C$7.00C$199,386.00171,324
9/13/2021Michael Robert MartinDirectorBuy25,000C$7.01C$175,230.00167,824
9/10/2021Robert HuizingaSenior OfficerSell32,500C$27.92C$907,335.00106,092
9/7/2021Michael Robert MartinDirectorSell7,500C$23.89C$179,190.00142,824
9/7/2021Robert HuizingaSenior OfficerSell5,000C$24.16C$120,780.00138,592
8/26/2021Michael Robert MartinDirectorSell22,500C$23.51C$528,957.00150,324
8/25/2021Neil SolomonsSenior OfficerSell5,000C$20.92C$104,610.00137,299
7/28/2021Michael Robert MartinDirectorSell5,000C$17.41C$87,073.00177,824
6/22/2021Michael Robert MartinDirectorSell5,000C$17.01C$85,050.00182,824
1/28/2021Stephen P. RobertsonSenior OfficerBuy900C$21.30C$19,174.322,720
9/21/2020Chin Kyu HuhInsiderSell48,458C$19.91C$964,988.546,499,881
8/18/2020Robert HuizingaSenior OfficerSell14,000C$19.01C$266,176.40103,592
7/8/2020Neil SolomonsSenior OfficerSell10,000C$21.15C$211,500.00187,299
4/9/2020Neil SolomonsSenior OfficerSell4,100C$21.04C$86,279.17197,299
4/6/2020Neil SolomonsSenior OfficerSell15,000C$21.11C$316,617.00202,299
1/2/2020Dennis BourgeaultSenior OfficerSell3,000C$27.62C$82,860.0070,891
12/16/2019Dennis BourgeaultSenior OfficerSell5,000C$24.08C$120,400.0073,891
12/12/2019Dennis BourgeaultSenior OfficerSell5,000C$24.55C$122,750.0016,452
10/15/2019Joseph Patrick HaganDirectorBuy2,000C$6.28C$12,553.203,500
10/14/2019Bradley DickersonSenior OfficerBuy5,000C$5.11C$25,542.0015,000
10/11/2019Joseph Patrick HaganDirectorBuy1,500C$5.11C$7,660.031,500
9/26/2019Stephen P. RobertsonSenior OfficerBuy1,050C$7.44C$7,812.001,820
7/1/2019Bradley DickersonSenior OfficerBuy2,000C$8.71C$17,424.007,000
4/25/2019Neil SolomonsSenior OfficerSell34,733C$8.44C$293,285.45253,266
4/23/2019Neil SolomonsSenior OfficerSell10,000C$8.53C$85,279.00287,999
See Full Table
Insider Selling at Aurinia Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aurinia Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Aurinia Pharmaceuticals (TSE:AUP)

Aurinia Pharmaceuticals logo
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Read More on Aurinia Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: C$16.08
Low: C$13.72
High: C$17.84

52 Week Range

Now: N/A

Volume

4,611,683 shs

Average Volume

229,895 shs

Market Capitalization

C$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals' top insider shareholders include:
  1. Chin Kyu Huh (Insider)
  2. Neil Solomons (Senior Officer)
  3. Robert Huizinga (Senior Officer)
  4. Michael Robert Martin (Director)
  5. Stephen P Robertson (Senior Officer)
Little-Known Stock Mints Money From Apple's iPhone
From Motley Fool   |   Ad
The one company 350x smaller than Apple that could capitalize on the potential collapse of the iPhone.
Learn More.